Calyxo is a medical device company that improves kidney stone treatment through specialized urology technologies.
Calyxo has raised $40.0M in total funding. The most recent round was Series F. The last funding was announced in April 2026.
Calyxo's investors include Janus Henderson Investors, Ally Bridge Group, Avidity Partners, Questa Capital Management, CRG.
Calyxo is headquartered in Pleasanton, United States.
Calyxo is a medical device company that improves kidney stone treatment through specialized urology technologies.
Calyxo is at the Series F stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Calyxo — Funding & Investors." VCBacked, April 14, 2026, https://www.vcbacked.co/company/calyxo. Accessed August 1, 2026.
VCBacked. (2026). Calyxo — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/calyxo
{{cite web |title=Calyxo — Funding & Investors |url=https://www.vcbacked.co/company/calyxo |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated